Gyre Therapeutics Inc (GYRE) Stock Price, Quote, News & History

GYRENASDAQ
$6.36
-0.11-1.7%
At close: Sep 1, 5:00 PM EST
$6.36
-0.11-1.7%
Pre-Market: 5:55 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-4.93M
Investing Cash Flow (TTM)
2.91M
Financing Cash Flow (TTM)
2.80M
Free Cash Flow (TTM)
-7.15M
Capital Expenditure (TTM)
-2.21M
Net Change in Cash (TTM)
774.00K

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$605.12M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
6.24
PB Ratio (TTM)
6.27
Earnings Yield % (TTM)
-3.29%
Earnings Yield % (FWD)
-6.43%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.02

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$43.29M
Debt to Equity
0.03
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$6.36
Volume / Avg.
0 / 79.30K
Day Range
- - -
52 Wk Range
5.44 - 9.42
Market Cap
$709.07M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
4.96%
Days to Cover
31.05

About

Sector
Health Care
Industry
Biotechnology
Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Gyre Therapeutics (GYRE) stock?

A

You can purchase shares of Gyre Therapeutics (NASDAQ:GYRE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Gyre Therapeutics (GYRE) competitors?

Q

What is the forecast, or price target, for Gyre Therapeutics (GYRE) stock?

A

Gyre Therapeutics has a consensus price target of $17.00.

Q

What is the current price for Gyre Therapeutics (GYRE)?

A

The stock price for Gyre Therapeutics (NASDAQ: GYRE) is $6.36 last updated September 2, 2026 at 4:00 PM EDT.

Q

Does Gyre Therapeutics (GYRE) pay a dividend?

A

There are no upcoming dividends for Gyre Therapeutics.

Q

When is Gyre Therapeutics (NASDAQ:GYRE) reporting earnings?

A

Gyre Therapeutics does not have any upcoming earnings scheduled.

Q

Is Gyre Therapeutics (GYRE) going to split?

A

There is no upcoming split for Gyre Therapeutics.

Q

What sector and industry does Gyre Therapeutics (GYRE) operate in?

A

Gyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.